image credit: MDP / Flickr

WHO lists Sinopharm’s COVID-19 vaccine for emergency use

The World Health Organization (WHO) has listed Sinopharm’s Vero Cell COVID-19 vaccine for emergency use, allowing it to be rolled out globally. Vero Cell is produced by Beijing Bio-Institute of Biological Products Co Ltd, a subsidiary of China National Biotec Group (CNBG).

“The addition of this vaccine has the potential to rapidly accelerate COVID-19 vaccine access for countries seeking to protect health workers and populations at risk,” commented Dr Mariângela Simão, WHO Assistant-Director General for Access to Health Products. “We urge the manufacturer to participate in the COVAX Facility and contribute to the goal of more equitable vaccine distribution.”

Read More on European Pharmaceutical Review